4GSD image
Deposition Date 2012-08-27
Release Date 2013-08-21
Last Version Date 2024-11-27
Entry Detail
PDB ID:
4GSD
Keywords:
Title:
H5.3 Fab Structure
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.25 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 61
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:H5.3 Fab Heavy Chain
Chain IDs:B (auth: H)
Chain Length:226
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:H5.3 Fab Light Chain
Chain IDs:A (auth: L)
Chain Length:212
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses.
J.Clin.Invest. 123 4405 4409 (2013)
PMID: 23999429 DOI: 10.1172/JCI69377

Abstact

Recent studies described the experimental adaptation of influenza H5 HAs that confers respiratory droplet transmission (rdt) to influenza virus in ferrets. Acquisition of the ability to transmit via aerosol may lead to the development of a highly pathogenic pandemic H5 virus. Vaccines are predicted to play an important role in H5N1 control should the virus become readily transmissible between humans. We obtained PBMCs from patients who received an A/Vietnam/1203/2004 H5N1 subunit vaccine. Human hybridomas were then generated and characterized. We identified antibodies that bound the HA head domain and recognized both WT and rdt H5 HAs. We used a combination of structural techniques to define a mechanism of antibody recognition of an H5 HA receptor-binding site that neutralized H5N1 influenza viruses and pseudoviruses carrying the HA rdt variants that have mutations near the receptor-binding site. Incorporation or retention of this critical antigenic site should be considered in the design of novel H5 HA immunogens to protect against mammalian-adapted H5N1 mutants.

Legend

Protein

Chemical

Disease

Primary Citation of related structures